View Older Stories View More Recent Stories

Oct 24, 2021 03:30PM Phathom Pharmaceuticals Announces New Data at ACG 2021 Annual Scientific Meeting
Oct 24, 2021 03:30PM Phathom Pharmaceuticals Announces New Data at ACG 2021 Annual Scientific Meeting
Oct 21, 2021 08:00AM Phathom Pharmaceuticals to Present New Data at ACG 2021 Annual Scientific Meeting
Oct 21, 2021 08:00AM Phathom Pharmaceuticals to Present New Data at ACG 2021 Annual Scientific Meeting
Oct 18, 2021 07:01AM Phathom Pharmaceuticals Inc. (PHAT) Reports Positive Topline Results from PHALCON-EE Pivotal Phase 3 Erosive Esophagitis Trial
Oct 18, 2021 07:00AM Phathom Pharmaceuticals (PHAT) Reports Positive Topline Results from PHALCON-EE Pivotal Phase 3 Erosive Esophagitis Trial
Oct 18, 2021 07:00AM Phathom Pharmaceuticals Announces Positive Topline Results from PHALCON-EE Pivotal Phase 3 Erosive Esophagitis Trial
Oct 18, 2021 07:00AM Phathom Pharmaceuticals Announces Positive Topline Results from PHALCON-EE Pivotal Phase 3 Erosive Esophagitis Trial
Sep 27, 2021 08:02AM Phathom Pharmaceuticals Inc. (PHAT) Announces Results VONO-103 Phase 1 Trial
Sep 27, 2021 08:00AM Phathom Pharmaceuticals Announces Results from VONO-103, a Phase 1 Study Evaluating Gastric Acid Inhibition of Vonoprazan and Lansoprazole (PREVACID®)
Sep 27, 2021 08:00AM Phathom Pharmaceuticals Announces Results from VONO-103, a Phase 1 Study Evaluating Gastric Acid Inhibition of Vonoprazan and Lansoprazole (PREVACID®)
Sep 20, 2021 08:00AM Phathom Pharmaceuticals Secures $200 Million Term Loan Facility from Hercules Capital
Sep 20, 2021 08:00AM Phathom Pharmaceuticals Secures $200 Million Term Loan Facility from Hercules Capital
Sep 8, 2021 08:08AM Phathom Pharmaceuticals (PHAT) Submits Two NDAs to U.S. FDA for Vonoprazan-based Treatment Regimens for the Treatment of H. pylori Infection
Sep 8, 2021 08:00AM Phathom Pharmaceuticals Submits Two NDAs to U.S. FDA for Vonoprazan-based Treatment Regimens for the Treatment of H. pylori Infection
Sep 8, 2021 08:00AM Phathom Pharmaceuticals Submits Two NDAs to U.S. FDA for Vonoprazan-based Treatment Regimens for the Treatment of H. pylori Infection
Aug 31, 2021 07:45AM Phathom Pharmaceuticals to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
Aug 31, 2021 07:45AM Phathom Pharmaceuticals to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
Aug 10, 2021 08:00AM Phathom Pharmaceuticals Reports Second Quarter 2021 Results and Provides Update Regarding Key Clinical and Regulatory Milestones
Aug 10, 2021 08:00AM Phathom Pharmaceuticals Reports Second Quarter 2021 Results and Provides Update Regarding Key Clinical and Regulatory Milestones
Aug 5, 2021 07:30AM Phathom Pharmaceuticals Mourns the Loss of Chairman and Founder, Tadataka "Tachi" Yamada, M.D.
Aug 5, 2021 07:30AM Phathom Pharmaceuticals Mourns the Loss of Chairman and Founder, Tadataka "Tachi" Yamada, M.D.
Aug 2, 2021 08:30AM Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI
Aug 2, 2021 08:30AM Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI
May 25, 2021 04:01PM Phathom Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
May 25, 2021 04:01PM Phathom Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
May 11, 2021 08:00AM Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates
May 11, 2021 08:00AM Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates
May 6, 2021 05:48PM Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
May 6, 2021 05:48PM Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
Apr 29, 2021 04:05PM Phathom Pharmaceuticals (PHAT) Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection Met All Primary and Secondary Endpoints
Apr 29, 2021 04:01PM Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints
Apr 29, 2021 04:01PM Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints
Apr 6, 2021 08:00AM Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference
Apr 6, 2021 08:00AM Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference
Mar 30, 2021 04:05PM Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
Mar 30, 2021 04:05PM Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
Jan 19, 2021 08:31AM Phathom Pharmaceuticals Inc. (PHAT) Reports Complete Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial
Jan 19, 2021 08:30AM Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial
Jan 19, 2021 08:30AM Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial
Dec 14, 2020 08:30AM Phathom Pharmaceuticals Announces Plans to Initiate Vonoprazan Development Program in Non-Erosive Reflux Disease (NERD)
Dec 14, 2020 08:30AM Phathom Pharmaceuticals Announces Plans to Initiate Vonoprazan Development Program in Non-Erosive Reflux Disease (NERD)
Nov 30, 2020 04:05PM Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Erosive Esophagitis Trial
Nov 30, 2020 04:05PM Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Erosive Esophagitis Trial
Nov 27, 2020 08:00AM Phathom Pharmaceuticals to Participate at Upcoming Investor Healthcare Conferences
Nov 27, 2020 08:00AM Phathom Pharmaceuticals to Participate at Upcoming Investor Healthcare Conferences
Nov 4, 2020 04:05PM Arcutis Announces Appointment of Terrie Curran to Board of Directors
View More Recent Stories View Older Stories